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ABSTRACT The degradation products of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) formed during
storage at 300C in aqueous solution were characterized. Cationic exchange chromatography of the stored sample showed
two major, new peaks eluting before (P1) and after (L2) the native protein, which were interconvertible. Size-exclusion
chromatography and electrophoresis documented that both the P1 and L2 fractions were irreversible dimers, formed by
noncovalent interactions. A competition assay with interleukin-1 indicated that on a per monomer basis the P1 and L2 dimers
retained about two-thirds of the activity of the native monomer. Infrared and far-UV circular dichroism spectroscopies showed
that only minor alterations in secondary structure arose upon the formation of the P1 dimer. However, alteration in the near-UV
circular dichroism spectrum suggested the presence of disulfide bonds in the P1 dimer, which are absent in the native protein.
Mass spectroscopy and tryptic mapping, before and after carboxymethylation, demonstrated that the P1 dimer contained an
intramolecular disulfide bond between Cys-66 and Cys-69. Although conversion of native protein to the P1 dimer was
irreversible in buffer alone, the native monomer could be regained by denaturing the P1 dimer with guanidine hydrochloride
and renaturing it by dialysis, suggesting that the intramolecular disulfide bond does not interfere with refolding. Analysis of
the time course of P1 formation during storage at 300C indicated that the process followed first-order, and not second-order,
kinetics, suggesting that the rate-limiting step was not dimerization. It is proposed that a conformational change in the
monomer is the rate-limiting step in the formation of the P1 dimer degradation product. Sucrose stabilized the native
monomer against this process. This result can be explained by the general stabilization mechanism for this additive, which
is due to its preferential exclusion from the protein surface.
INTRODUCTION
Development of a protein therapeutic agent requires not
only production of a sufficient quantity of homogeneous,
highly active protein, but also a stable formulation suitable
for storage and delivery. Obtaining such formulations is
often difficult because of the intrinsic instability of proteins
in aqueous solutions, which are often the preferred mode of
preparation. One of the most common manifestations of
protein damage during storage in aqueous solution is the
formation of non-native protein aggregates, which often
precipitate (Arakawa et al., 1993). These aggregated mole-
cules are very similar to those formed during short-term
thermal unfolding experiments. The unfolded molecules
associate into aggregates that characteristically have a high
content of non-native intermolecular (3 sheet structure
(Dong et al., 1995).
The first goal of the current study was to characterize the
degradation products formed during long-term storage of
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recombinant human interleukin- 1 receptor antagonist (rhIL-
Ira) in aqueous solution. This was of interest because rhIL-
Ira belongs to a structural class of proteins, including acidic
and basic fibroblast growth factors (aFGF and bFGF), ke-
ratinocyte growth factor (KGF), and interleukin-l (IL-1), all
of which show extensive precipitation of non-native mole-
cules upon long-term storage in aqueous solution at mod-
erate temperatures; i.e., above room temperature, but lower
than the respective proteins' melting temperatures (Gu et
al., 1991; Tsai et al., 1993; Kajio et al., 1992; Volkin et al.,
1993; Chen et al., 1994). The X-ray crystal structure of
IL-Ira (Vigers et al., 1994) shows that it consists of 12
(3-strands, which are folded into an overall topology similar
to that observed with aFGF, bFGF, and IL-1 (Finzel et al.,
1989; Priestle et al., 1989; Graves et al., 1990; Ago et al.,
1991; Clore et al., 1991; Eriksson et al., 1991; Zhang et al.,
1991; Zhu et al., 1991; Shaanan et al., 1992). The native
forms of all of these proteins are monomeric with no ten-
dency to associate reversibly into native dimers and oli-
gomers (Arakawa et al., 1993; Wen et al., 1996; J. Wen, J.
S. Philo, and T. Arakawa, unpublished observation; B.
Brandhuber, private communication). Based on this back-
ground we fully expected to find that rhILl-ra would also
form extensive, non-native protein aggregates during stor-
age. However, as detailed below we were surprised to find
that the major degradation product was a dimer that formed
irreversibly, but which retained very native-like structure
and biological activity.
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The second goal of the current study was to determine
whether approaches used to ameliorate aggregation of
aFGF, bFGF, KGF, and IL-1 would also attenuate forma-
tion of the dimeric species of rhIL-lra. This is an intriguing
question because it has been shown that in cases where
non-native aggregates are produced, kinetic stability can be
improved with the addition of co-solvents (e.g., polyols,
sugars, or polymers) or specific ligands that are known to
increase the thermodynamic stability of the native monomer
(Gerlsma, 1968, 1970; Frigon and Lee, 1972; Lee and
Timasheff, 1981; Arakawa and Timasheff, 1982, 1985; Ti-
masheff, 1992, 1995; Arakawa et al., 1993; Volkin et al.,
1993; Chen et al., 1994; Vrkljan et al., 1994; Liu and Bolen,
1995). Aggregation is attenuated because formation of the
unfolded form, which serves as the precursor of the non-
native aggregates, is thermodynamically less favorable. The
same co-solvents that cause this increase in the free energy
of denaturation of monomers are also known to foster
assembly of polymerization-competent proteins into the
higher-order native oligomers (Timasheff, 1992, 1995; Ara-
kawa et al., 1993). Thus, if the formation of the dimeric
form of rhIL-Ira is due to self-association of the native
monomer during storage, one might expect sucrose to ac-
celerate this process. In contrast we found that, as with
proteins that form non-native aggregates, sucrose inhibited
formation of the rhIL-ira dimer. The putative mechanism
for this effect, as well as the detailed structural character-
ization of the dimer, are described below.
MATERIALS AND METHODS
Pharmaceutical-quality rhIL-Ira was produced and purified at Amgen
Boulder (formerly Synergen). The protein was greater than 99.5% homo-
geneous based on size-exclusion chromatography and approximately 98%
pure based on cation-exchange chromatography. Protein solutions (100
mg/ml) containing various concentrations of sugar were prepared in 10
mM sodium citrate buffer (pH 6.5 at 23°C) and 140 mM sodium chloride,
and stored at 30°C until analysis. Control samples were stored at -70°C.
High performance liquid chromatography
High performance liquid chromatography (HPLC) analyses were carried
out on a Beckman HPLC system, which was interfaced with system GOLD
(Beckman Instruments Inc., Fullerton, CA) for programming and data
acquisition. Cation-exchange HPLC (CEX-HPLC) was carried out using a
Biogel® SP-5-PW column (7.5 mm X 7.5 cm, BioRad Laboratories,
Hercules, CA), a flow rate of 0.5 m/min and 20 mM MES (pH 5.5) as a
running buffer. After an injection of 500 u±g protein, the protein was eluted
with a linear 0 to 1 M sodium chloride gradient. Size-exclusion chroma-
tography HPLC (SEC-HPLC) was carried out using a TSK-Gel® G2000
SWXL column (7.8 min x 30 cm, TosoHaas, Montgomeryville, PA), a
flow rate of 0.5 ml/min, and 10 mM sodium citrate (pH 6.5) with 140 mM
sodium chloride as the running buffer. For each analysis, 500 ,ug protein
was injected.
Potency bioassay
The potency of rhIL-Ira was measured by its ability to inhibit the effect of
interleukin- loa (IL- I a). IL- la is cytotoxic to the human melanoma cell line
A375, clone 6-14 (obtained from K. Matsushima, in J.J. Oppenheim's lab,
Laboratory of Immunoregulation, Biological Response Modifier Program,
Division of Cancer Treatment, National Cancer Institute, National Insti-
tutes of Health, Frederick Cancer Research Facility, Frederick, MD).
rhIL-lra inhibits IL-la cytotoxicity in a dose-dependent manner. A375
cells were treated with serial dilutions of rhIL-ira standard and samples in
the presence of 1 ng/ml IL-la. Cell survival at approximately 72 h was
assessed by the addition of a solution of XTT (sodium 3,3'-{i-[(phe-
nylamino) carbonyl]-3,4-tetrazolium}-bis(4-methoxy-6-nitro) benzene sul-
fonic acid hydrate) and menadione. Surviving cells metabolize XTT to a
water-soluble formazan product, which was quantitated by measurement of
optical density (Roehm et al., 1991). Dose-response curves were fit to a
weighted four-parameter logistic model, and ED50 values were calculated.
Fourier transform infrared (FTIR) spectroscopy
Infrared spectra of aqueous protein solutions were recorded at 23°C with a
Nicolet Magna 550 Fourier transform infrared spectrometer (Nicolet In-
struments Co., Madison, WI), equipped with a dTGS detector. Protein
solutions (54 mg/ml in 10 mM citrate, 140 mM NaCl at pH 6.5) were
prepared for infrared measurement in a sample cell (Beckman FH-01) that
used CaF2 windows separated by a 6-mm spacer. For each spectrum, a
256-scan interferogram was collected in single beam mode, with a 4 cm-'
resolution. The reference spectra were recorded under identical conditions
with only buffer in the cell. The spectra for liquid and gaseous water were
subtracted from the protein spectra, as appropriate, according to previously
established criteria (Dong et al., 1990; Dong and Caughey, 1994). The final
protein spectrum was smoothed with a seven-point function to remove
white noise. Second derivative spectra were calculated with the derivative
function of Nicolet Omnic software.
Circular dichroism (CD) spectroscopy
CD spectra were determined on a Jasco J-SOOC spectropolarimeter (Jasco
Inc., Easton, MD) using a 1-cm pathlength cuvette for the near-UV and a
0.02 cm pathlength cuvette for the far-UV. The spectra shown are the
average of 10 accumulations, and were calculated assuming an E801% of
0.77 at 280 nm for the rhIL-ira solution and a mean residue weight of
112.8. Protein solutions of I to 1.4 mg/ml in 10mM citrate, 140mM NaCl
at pH 6.5 were studied. The secondary structure was estimated based on a
previously published computational method (Greenfield and Fasman,
1969).
ANS binding
The 1,8-anilinonaphthalenesulfonate (ANS) binding assay was performed
on an SLM Aminco 500 spectrofluorometer, using protein solutions of 0.2
mg/ml, a cuvette with a 0.5-cm pathlength, and slit widths of 5 mm. After
first recording the intrinsic fluorescence upon excitation at 280 nm, in-
creasing amounts of ANS were added, and the spectra from 400 to 520 nm
recorded upon excitation at 380 nm.
Tryptic mapping and mass spectrometry
Tryptic mapping of rhIL-Ira was initiated by denaturing 1 mg/ml protein
with 1.6 M guanidine hydrochloride in the presence 0.7 mM iodoacetic
acid. Reducing agent was not used to preserve disulfide bonds during
digestion. The denatured protein was digested with trypsin overnight at
37°C. The digested sample was analyzed with reversed-phase HPLC using
a Vydac C4 column (4.6 mm X 25 cm, 5 ,um particle size). Acetonitrile
was used to develop a gradient from 0 to 60%.
Mass spectrometry was carried out using a Sciex triple quadripole mass
spectrometer (Perkin-Elmer Sciex Instruments, Thornhill, Ontario, Can-
ada) calibrated with polypropylene mass standards. Mass determination
was performed on samples purified on reverse phase HPLC, which were
infused at 10 m/min and ionized by an orifice potential of 70 V. Sample
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ion streams were scanned in the first quadripole from 400 to 2400 atomic
mass units (amu). Deconvolution of raw mass data was performed using
Mac Biospec software provided by Sciex.
Curve-fitting for the order of reaction
The formation of P1 dimer was monitored with 100 mg/ml rhIL-ira
solution during storage at 300C, as described above. Samples were with-
drawn at various times and analyzed with CEX-HPLC to determine the
amount of P1. To calculate the rate of P1 formation, the following general
equation (Benson, 1960) was used.
d[Pi]
dt =4
where d[Pl]/dt is the change in the concentration of native rhIL-Ira
monomer to form P1 dimer with time (days), [C] is the concentration of
native rhIL-ira monomer, k is the rate constant in appropriate units, and n
is the order of the reaction. For a first-order reaction, a semilogarithmic
coordinate (log[Pl]) is needed to produce a linear plot. In contrast, a plot
of I/[PI] versus time produces a linear relationship for a second-order
reaction.
RESULTS AND DISCUSSION
Structure and function of degradation products
arising during storage of rhIL-1ra
In contrast to previous results with aFGF, bFGF, KGF, and
IL-1, long-term storage (at 30°C) of aqueous solutions of
rhIL-Ira resulted only a relatively small production of vis-
ible precipitates (approximately <1% of total protein). To
determine the other, more dominant, degradation products,
the stored sample was filtered with a 0.2-,um membrane to
remove precipitated material and analyzed by various chro-
matographic procedures. Among many techniques tested
(data not shown), CEX-HPLC provided the best separation
of these products. Fig. 1 shows the CEX-HPLC chromato-
grams of rhIL-Ira before and after storage for 2 months at
300C. Various peaks shown were significantly increased
during storage. Of the degradation products represented by
these peaks, the fraction eluting (designated as P1) just
before the native protein was the major species; it consti-
tuted 8% of the total peak area, including the native peak.
The P1 fraction was collected and analyzed with various
biochemical and biophysical techniques to characterize the
nature of the modifications that had occurred.
Reinjection of the P1 fraction onto the CEX-HPLC col-
umn resulted in two peaks, P1 and L2 (so designated be-
cause it was the second fraction eluting after the native
protein), indicating that these two forms are isomers (Fig.
1). Reinjection of the L2 also resulted in the appearance of
a P1 peak (data not shown). Why these isomeric forms have
different retention times in CEX-HPLC is not clear. More
importantly, whenever P1 and L2 were reinjected there was
not the appearance of the peak for native protein in the
chromatogram (Fig. 1 and data not shown). These results
document that the formation of the P1 and L2 degradation
products is not reversible, under these conditions.
a
45
Retentlon Time (minutes)
FIGURE 1 CEX-HPLC chromatograms of rhIL-lra and purified P1
fraction. The experimental sample was incubated for 2 months at 30°C and
the control rhIL-lra sample was stored for 2 months at -70°C.
Reinjection of the P1 fraction onto an SEC-HPLC col-
umn demonstrated that P1 was a dimeric form of rhIL-Ira
(Fig. 2). The L2 fraction was also the dimeric form of
rhIL- lra (data not shown). Inasmuch as SDS-PAGE showed
a monomeric molecular weight (data not shown), these
dimers are formed by noncovalent interactions.
10 12 14 16 18
Retention Time (minutes)
FIGURE 2 Analysis of purified P1 fraction by SEC-HPLC. The dimer
shown in the chromatogram was confirmed using molecular weight stan-
dards.
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As noted in the Introduction, irreversibly aggregated deg-
radation products formed from proteins, which are structur-
ally similar to rhIL- Ira, are largely unfolded, and often such
aggregates contain a high degree of intermolecular ,3 sheet
structure (Dong et al., 1995). To determine whether this was
true for the formation of a soluble dimer of rhIL-Ira, we
examined the structure of the purified P1 fraction with a
number of biophysical methods. First, the secondary struc-
ture of the native and dimeric protein was compared using
infrared spectroscopy. The second derivative spectra in the
conformationally sensitive amide I region (Susi and Byler,
1983) were very similar for the two protein forms (Fig. 3)
and were characteristic of predominantly ,B sheet proteins
(Dong et al., 1990; Dong and Caughey, 1994). The spec-
trum for the dimer had slightly greater absorbances for the
bands at 1642 and 1691 cm- 1, which are due to intramo-
lecular 3 sheet structure. This increase in absorbance was
compensated by a slight reduction in absorbance in the ,B
turn region of 1660-1685 cm-1 (Dong and Caughey, 1994).
Also, the characteristic infrared bands for the intermolecular
13 sheet were not present in the spectra of either protein form
(Fig. 3). For proteins prepared in H20, intermolecular (3
sheet gives rise to a strong band in the 1615-1625 cm-'
region and a weaker band in the 1690-1699 cm-' region
(Dong et al., 1995). Taken together, these infrared spectro-
scopic results demonstrate that the secondary structure of
the P1 dimer is very native-like and has only a slight
increase in intramolecular ,3 sheet content relative to that of
the native monomer.
These results were corroborated with CD spectroscopy.
The far-UV CD spectrum (Fig. 4 A) of the P1 dimer was
slightly different from that of the native protein, and indi-
.
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FIGURE 3 Second-derivative amide I infrared spec
( ) and the P1 dimer (. ).
A
0
I3
-5
195 200 210 220 230 240 250
Wavelength (nm)
B
150
100-
50
-50
-100 i
-150
240 250 260 270 280 290 300 310 320 330 340
Wavelength (nm)
FIGURE 4 Circular dichroism analysis of native rhIL-Ira ( ) and the
P1 dimer (----). (A) Far-UV analysis and (B) Near-UV analysis.
cated that the (3 sheet content of the secondary structure was
only slightly increased in the P1 dimer relative to native,
monomeric protein. Also, it appears that the environment of
the aromatic amino acids responsible for the 231-nm peak
were only slightly altered by dimer formation. The near-UV
CD spectra (Fig. 4 B) did suggest the possibility of a small
change in tertiary structure. The overall shape of the spec-
trum for the native protein, including features attributable to
Trp (280-300 nm) and Tyr (270-280 nm), was retained in
the spectrum for the P1 dimer, but the absolute intensity of
the signal throughout the near-UV CD region was more
positive in the P1 form. There also appeared to be a differ-
ence in the features at 250-260 nm, which could be attrib-
utable to an alteration in the local environment of Phe.
However, because disulfides have a broad signal in this
spectral region, the changes in the spectrum could be ob-
served if cysteines had formed a disulfide in the P1 dimer.
Native rhIL-ira contains no disulfide bonds. The four cys-
teines, Cys-66, Cys-69, Cys-1 16, and Cys-122 exist in a free
1620 1600 form in the native protein (Eisenberg et al., 1990). The
observation that the P1 dimer is dissociated during SDS-
PAGE implies that disulfide bonds are not formed at the
tra of native rhIL- lra intermolecular contacts. However, tryptic mapping indi-
cated that intramonomer disulfide bonds had formed in the
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P1 dimer. Comparison of the tryptic map of the native
protein and the P1 dimer showed a shift of one tryptic peak,
T8, which contains Cys-66 and Cys-69 (data not shown).
The two cysteines are present in free form in the native
monomer and available for reaction during carboxymethy-
lation. This treatment of the sample before trypsin digestion
gave a molecular weight (by mass spectrometry) of the T8
peptide from native rhILl-ra as 899 amu. In contrast, mass
spectrometry analysis of the P1 dimer after the same treat-
ment gave a molecular weight of 793 amu, which is less
than the value for the T8 peptide from the native monomer
by the mass of two carboxymethylated groups. This result
indicates that Cys-66 and Cys-69 in the P1 degradation
product were no longer in free form due to the presence of
an intramonomer disulfide bond. Based on the proximity of
these residues (Vigers et al., 1994), the formation of the
disulfide bond is not unexpected and agrees with the ob-
served change in the near-UV CD spectra upon dimer
formation. However, as discussed below, this disulfide for-
mation does not greatly reduce antagonistic potency activity
of the P1 dimer, nor does it prohibit refolding of this
species.
To probe further for conformational alterations in the P1
dimer, the overall surface hydrophobicity was assessed by
ANS binding. ANS is a hydrophobic dye that fluoresces
upon binding to hydrophobic patches on the surface of
proteins (Semisotnov et al., 1991). Addition of up to 200
mM ANS to both the P1 dimer and the native monomer
resulted in identical, very low, fluorescence at 500 nm (data
not shown). This result indicates that both species have
essentially equivalent, very hydrophilic exposed surfaces.
The structural analyses all indicated that the P1 dimer has
a very native-like structure. To determine whether this
structural retention corresponded to maintenance of biolog-
ical activity of the protein, the in vitro antagonistic poten-
cies of the P1 and L2 dimers were compared with those of
the native monomer. The dose dependencies of competition
with IL-la are shown in Fig. 5. The shape of the fitted
curves were very similar for all three samples, demonstrat-
ing that the P1 and L2 dimers competed with IL-la in a
similar fashion to the native monomer. The dose response
curves for the dimers were shifted to about a threefold
higher concentration, indicating that they are about one-
third as active as the native protein. Because IL- a is a
monomeric ligand, only one subunit in the P1 dimer would
be expected to bind the receptor. Hence the activity of
P1 and L2 dimers is theoretically expected at most to be
one-half that of the native monomer. The observed activity,
therefore, indicates that on a per monomer basis the
dimers retained about two-thirds of the activity of the native
monomer.
All of these spectroscopic and biological data indicate
that the P1 has a native-like folded structure that is only
slightly different from that of the native monomer. There are
two distinct possibilities as to how this novel degradation
product is formed. First, the dimer could be formed from
random contact between two native monomers in an appro-
3.5 - A L2 ED50 = 5.69 ± 0.76 ng/ml
m P1 ED50 =6.75 0.75 ng/ml
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FIGURE 5 Potency bioassay of native rhIL-ira and purified P1 or L2
dimers. ED50 values include their standard deviations.
priate orientation and, hence, the rate of formation of the P1
dimer should follow second-order kinetics. In this mecha-
nism, the minor conformational changes (e.g., formation of
intramonomer disulfide bond) would arise after dimeriza-
tion. Second, there could be a transition of the native mono-
mer into an intermediate, mostly folded state, which then
associates into the dimer. In this case it is expected that rate
of dimerization would follow first-order kinetics. To ad-
dress this issue the time course of P1 dimer formation was
compared with curves expected for first- and second-order
reactions, as shown in Fig. 6. The results fit best with a
first-order reaction, which is consistent with the hypothesis
that a conformational change in the native monomer is
responsible for P1 formation and is the rate-determining
step.
Renaturation of the P1 dimer
The conversion of monomer to the P1 dimer is irreversible,
as shown by the lack of appearance of the native monomer
upon injection of purified P1 into a CEX-HPLC or a SEC-
HPLC system (Figs. 1 and 2). However, the P1 dimer could
be converted to the native monomer with a denaturation/
refolding treatment. From the dose response for unfolding
in the presence of guanidine hydrochloride, as assessed by
alterations in intrinsic fluorescence, it was established that
the midpoint for protein denaturation was 1.6 M guanidine
hydrochloride and that the protein was fully denatured in 2.5
M guanidine hydrochloride (data not shown). Starting with
the fully denatured form in 2.5 M guanidine hydrochloride,
the protein was refolded by dialyzing it against 10 mM
sodium citrate buffer with 140 mM NaCl at pH 6.5. The
refolded material was analyzed by CEX-HPLC (Fig. 7 A).
* N ED50 = 2.15 t 0.17 log/rnl
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FIGURE 6 Fitting of data for P1 dimer formation as a function of
storage time to equations for first-order (A) and second-order (B) reactions
(see Methods).
The majority of the refolded protein eluted at the position
for the native monomer, indicating that the intramonomer
disulfide formation in the P1 form did not interfere with
refolding. Surprisingly, a small peak was also observed at
20 25 30 35 40 45
Retention Time (minutes)
FIGURE 7 CEX-HPLC chromatograms of renatured P1 (A) and native
rhIL-Ira (B). Each sample was denatured with 2.5 M guanidine hydrochlo-
ride and dialyzed against 10 mM sodium citrate buffer with 140 mM NaCl
at pH 6.5.
the P1 position, suggesting that the refolding process gen-
erates the P1 dimer as well as native monomer. When the
native monomer was denatured with 2.5 M guanidine hy-
drochloride and refolded and analyzed as described above,
it generated not only the native monomer but also a small
amount of P1 dimer (Fig. 7 B). These results suggest that
during the course of refolding from the denatured state the
requisite monomeric conformation for formation of the P1
dimer can be generated.
Effect of sucrose on rhlL-1ra stability
Sucrose and other stabilizing co-solvents, which are known
to increase the free energy of protein denaturation (Lee and
Timasheff, 1981; Arakawa and Timasheff, 1982, 1985; Ti-
masheff, 1992, 1995; Arakawa et al., 1993), have been
shown to reduce formation of non-native protein aggregates
during storage in aqueous solution (Wilson, 1970; Frigon
and Lee, 1972; Gu et al, 1991; Tsai et al, 1993; Chen et al.,
1994). As noted in the Introduction, this effect is the result
of making less favorable the denatured state needed for
aggregate formation. In contrast, the formation of the P1
dimer does not appear to be associated with denaturation of
the monomer. Because the dimer is mostly native in struc-
ture, it might be expected that the capacity of a co-solvent
such as sucrose to foster polymerization of native proteins
(cf. Timasheff 1992, 1995; Arakawa et al., 1993) could
enhance the rate of production of the P1 dimer. However,
the generation of P1 and L2 dimers during storage of
rhIL- 1ra was greatly reduced by the addition of sucrose in a
concentration-dependent manner (Fig. 8). With sucrose con
20 25 30 35 40 45 50
Retention Time (min)
FIGURE 8 CEX-HPLC chromatograms of rhIL-Ira samples containing
various sucrose concentrations after 2 months of storage at 30°C. Numbers
shown in the figure represent the concentration of sucrose (w/v).
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centrations '40% (w/v) these degradation products were
almost undetectable after 2 months of storage at 30°C. The
same trend was observed when sorbitol was included in-
stead of sucrose (data not shown).
Possible mechanisms of P1 dimer formation and
stabilizing effect of sucrose
Taken together, our results indicate that the overall structure
of the dimeric P1 degradation product is only slightly al-
tered relative to that of the native monomeric rhIL-lra. The
first-order reaction kinetics suggest that the rate-limiting
step could be conversion of the monomeric native protein
into a monomeric form with slightly altered structure, which
serves as the precursor for formation of dimers. The obser-
vation that the structural stabilizer (sucrose) inhibits the
formation of the P1 dimer also suggests that there must be
at least some perturbation of conformation involved in the
dimerization, based on the following arguments.
Timasheff and colleagues (Lee and Timasheff, 1981;
Arakawa and Timasheff, 1982) have shown that sucrose and
other structural stabilizers exert their effects because they
are preferentially excluded from the protein's surface,
which increases protein chemical potential. By the principle
of Le Chatelier, at equilibrium the system will tend to
minimize this thermodynamically unfavorable effect by re-
ducing the surface area of the protein from which the
co-solvent is excluded. Thus, the protein state with the
lowest surface area of exposure to the solvent will be
favored. When a protein is in equilibrium between native
and denatured states, in the presence of a preferentially
excluded co-solvent, the increase in protein chemical po-
tential is greatest for the latter state, which has the greatest
surface area. Hence, the free energy of denaturation is
increased and the native state is stabilized.
In the case of sucrose-induced inhibition of P1 dimer
formation of rhIL- Ira, we propose that sucrose affects the
reversible conversion of native monomer (N) to an interme-
diate form (I) in favor of N, because there is an increase in
protein surface area upon formation of I. Also, Liu and
Bolen (1995) have recently shown that the unfavorability of
exposing the peptide backbone to solvent increases in the
presence of sucrose. Such exposure could arise during for-
mation of I in our system.
The inhibition of the formation of P1 dimer by sucrose
also argues against dimerization from initially fully native
molecules. This is because-also by the Principle of Le
Chatelier-in the presence of a preferentially excluded co-
solvent the formation of oligomeric species would be fa-
vored because the overall surface area of the protein mole-
cules would be reduced by polymerization. Hence, even
though the formation of the P1 dimer is an irreversible step,
it would be expected that sucrose would accelerate this
process if the native protein monomer was the form in-
volved in dimerization.
To summarize, we suggest that the formation of the P1
degradation product occurs as follows:
N¢.I -> P1
The native monomer is in equilibrium with a monomeric
intermediate leading to P1, termed I. This conversion from
N to I could itself be irreversible. However, the apparent
stabilization of the native monomer by sucrose suggests that
there may be an equilibrium step during P1 formation, as
described in this scheme. To our knowledge there have not
been other published reports documenting the formation of
active, oligomeric degradation products of proteins by this
or other pathways. More research with other proteins is
needed to determine whether this behavior is unique to
rhIL- Ira.
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